Ramona Cassin Selected Research

Platelet Storage Pool Deficiency

1/2022

Acquired hemophilia A and delta storage pool deficiency in a patient with indolent non-Hodgkin lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ramona Cassin Research Topics

Disease

10	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 11/2015
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2021 - 02/2013
3	Lymphoma (Lymphomas) 01/2022 - 02/2013
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 02/2013
2	Hemorrhage 01/2022 - 11/2018
2	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 10/2018
2	Neutropenia 12/2021 - 03/2017
1	Hemophilia A (Haemophilia) 01/2022
1	Platelet Storage Pool Deficiency 01/2022
1	Neoplasms (Cancer) 01/2022
1	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 11/2021
1	Hemolytic Anemia 11/2021
1	Infections 02/2021
1	Iron Overload 01/2021
1	COVID-19 07/2020
1	BCR-ABL Negative Atypical Chronic Myeloid Leukemia (Leukemia, Myeloid, Philadelphia Negative) 10/2019
1	Aplastic Anemia (Anemia, Hypoplastic) 08/2019
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 08/2019
1	Atrial Fibrillation 11/2018
1	Acute Promyelocytic Leukemia 03/2017
1	Leukemia 03/2017
1	Hematologic Neoplasms (Hematological Malignancy) 03/2017
1	Pdgfra-Associated Chronic Eosinophilic Leukemia 04/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 02/2013
1	Multiple Myeloma 02/2013
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2013

Drug/Important Bio-Agent (IBA)

7	ibrutinibIBA 01/2022 - 11/2018
3	Rituximab (Mabthera)FDA Link 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 03/2017
2	venetoclaxIBA 01/2022 - 01/2019
2	Azacitidine (5 Azacytidine)FDA Link 10/2021 - 10/2018
2	Pharmaceutical PreparationsIBA 08/2019 - 11/2018
1	recombinant FVIIa (rFVIIa)FDA Link 01/2022
1	Prednisone (Sone)FDA LinkGeneric 01/2022
1	AutoantibodiesIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Factor VIII (Coagulation Factor VIII)IBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	ruxolitinibIBA 01/2022
1	AgglutininsIBA 11/2021
1	Proteins (Proteins, Gene)FDA Link 10/2021
1	idelalisibIBA 04/2021
1	Immunoglobulin A (IgA)IBA 02/2021
1	Bendamustine Hydrochloride FDA Link 01/2021
1	Erythropoietin FDA Link 01/2021
1	Decitabine FDA Link 10/2019
1	eltrombopag FDA Link 08/2019
1	Inosine Triphosphate (ITP)IBA 08/2019
1	Thrombopoietin ReceptorsIBA 08/2019
1	Amiodarone (Amiodarona)FDA LinkGeneric 11/2018
1	Biomarkers (Surrogate Marker)IBA 07/2017
1	Alemtuzumab (Campath)FDA Link 11/2015
1	Imatinib Mesylate (Gleevec)FDA Link 04/2014
1	Immunomodulating AgentsIBA 02/2013

Therapy/Procedure

6	Therapeutics 01/2022 - 03/2017
1	Blood Transfusion (Blood Transfusions) 01/2021
1	Continuity of Patient Care 07/2020
1	Immunomodulation 08/2019
1	Drug Therapy (Chemotherapy) 03/2017
1	Treatment Delay 03/2017